Assessment of antimicrobial susceptibility of enterococcus faecalis isolated from chronic periodontitis in biofilm versus planktonic phase

Journal of Periodontology

Volumn 82, Issue 4, 2011, Pages 626-631

  Sun, Jinglu ^a   Song, Xiaobo ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Antimicrobial agents; Biofilm; Chronic periodontitis; Drug resistance; Enterococcus faecalis; Planktonic

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; BIOFILM; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ENTEROCOCCUS FAECALIS; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; TOOTH PLAQUE;

ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTERIAL ADHESION; BACTERIAL TYPING TECHNIQUES; BIOFILMS; CHRONIC PERIODONTITIS; COLONY COUNT, MICROBIAL; DENTAL PLAQUE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 79954987861     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100378     Document Type: Article

References (45)

1. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996-1011.
2. (erratum 2009;30:107).
3. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev 1994;7:462-478.
4. Clewell DB. Movable genetic elements and antibiotic resistance in enterococci. Eur J Clin Microbiol Infect Dis 1990;9:90-102. (Pubitemid 20074226)
5. Lleo M, Bonato B, Tafi MC, Caburlotto G, Benedetti D, Canepari P. Adhesion to medical device materials and biofilm formation capability of some species of enterococci in different physiological states. FEMS Microbiol Lett 2007;274:232-237. (Pubitemid 47256262)
6. Toledo-Arana A, Valle J, Solano C, et al. The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. APPL Environ Microbiol 2001;67:4538-4545. (Pubitemid 33646082)
7. Mohamed JA, Huang DB. Biofilm formation by enterococci. J Med Microbiol 2007;56:1581-1588. (Pubitemid 350276505)
8. Sandoe JA, Witherden IR, Cove JH, Heritage J, Wilcox MH. Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo. J Med Microbiol 2003;52:547-550. (Pubitemid 36871891)
9. Sundqvist G, Figdor D. Life as an endodontic pathogen: Ecological differences between the untreated and root-filled root canals. Endodontic Topics 2003;6:3-28.
10. Takemura N, Noiri Y, Ehara A, Kawahara T, Noguchi N, Ebisu S. Single species biofilm-forming ability of root canal isolates on gutta-percha points. Eur J Oral Sci 2004;112:523-529. (Pubitemid 39627034)
11. Distel JW, Hatton JF, Gillespie MJ. Biofilm formation in medicated root canals. J Endod 2002;28:689-693.
12. Pinheiro ET, Gomes BP, Drucker DB, Zaia AA, Ferraz CC, Souza-Filho FJ. Antimicrobial susceptibility of Enterococcus faecalis isolated from canals of root filled teeth with periapical lesions. Int Endod J 2004;37: 756-763. (Pubitemid 39462936)
13. Dahlén G, Samuelsson W, Molander A, Reit C. Identification and antimicrobial susceptibility of enterococci isolated from the root canal. Oral Microbiol Immunol 2000;15:309-312.
14. Kinane DF, Lindhe J, Trombelli L. Chronic periodontitis. In: Lindhe J, Lang NP, Karring T, eds. Clinical Periodontology and Implant Dentistry, vol.2. Oxford: Wiley-Blackwell; 2008:420-423.
15. Marsh PD. Plaque mediated diseases - Dental caries and periodontal diseases. In: Marsh PD, Martin MV, eds. Oral Microbiology, 5th ed. Edinburgh: Elsevier; 2009:103-145.
16. Handal T, Caugant DA, Olsen I. Antibiotic resistance in bacteria isolated from subgingival plaque in a Norwegian population with refractory marginal periodontitis. Antimicrob Agents Chemother 2003;47: 1443-1446. (Pubitemid 36368616)
17. Wiebe CB, Putnins EE. The periodontal disease classification system of the American Academy of Periodontology - An update. J Can Dent Assoc 2000;66: 594-597.
18. Colombo AP, Haffajee AD, Dewhirst FE, et al. Clinical and microbiological features of refractory periodontitis subjects. J Clin Periodontol 1998;25:169-180. (Pubitemid 128705949)
19. Olsvik B, Hansen BF, Tenover FC, Olsen I. Tetracyclineresistant micro-organisms recovered from patients with refractory periodontal disease. J Clin Periodontol 1995; 22:391-396.
20. Balaei-Gajan E, Shirmohammadi A, Abashov R, Agazadeh M, Faramarzie M. Detection of Enterococcus faecalis in subgingival biofilm of patients with chronic refractory periodontitis. Med Oral Patol Oral Cir Bucal 2010;15:e667-e670.
21. Souto R, Colombo AP. Prevalence of Enterococcus faecalis in subgingival biofilm and saliva of subjects with chronic periodontal infection. Arch Oral Biol 2008;53:155-160. (Pubitemid 350296034)
22. Rams TE, Feik D, Young V, Hammond BF, Slots J. Enterococci in human periodontitis. Oral Microbiol Immunol 1992;7:249-252.
23. Sun J, Song X, Kristiansen BE, et al. Occurrence, population structure, and antimicrobial resistance of enterococci in marginal and apical periodontitis. J Clin Microbiol 2009;47:2218-2225.
24. Harrison JJ, Ceri H, Yerly J, et al. The use of microscopy and three-dimensional visualization to evaluate the structure of microbial biofilms cultivated in the Calgary Biofilm Device. Biol Proced Online 2006;8:194-215.
25. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001;48 (Suppl. 1):5-16.
26. Melchior MB, Fink-Gremmels J, Gaastra W. Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture. J Vet Med B Infect Dis Vet Public Health 2006;53:326-332. (Pubitemid 44286057)
27. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999;37:1771-1776. (Pubitemid 29235221)
28. Tendolkar PM, Baghdayan AS, Gilmore MS, Shankar N. Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun 2004;72:6032-6039. (Pubitemid 39303718)
29. Kristich CJ, Li YH, Cvitkovitch DG, Dunny GM. Espindependent biofilm formation by Enterococcus faecalis. J Bacteriol 2004;186:154-163. (Pubitemid 38020297)
30. Hancock LE, Perego M. The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J Bacteriol 2004; 186:5629-5639. (Pubitemid 39128635)
31. Mohamed JA, Huang W, Nallapareddy SR, Teng F, Murray BE. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect Immun 2004;72:3658-3663. (Pubitemid 38697799)
32. Pillai SK, Sakoulas G, Eliopoulos GM, Moellering RC Jr., Murray BE, Inouye RT. Effects of glucose on fsrmediated biofilm formation in Enterococcus faecalis. J Infect Dis 2004;190:967-970. (Pubitemid 39120974)
33. Baldassarri L, Cecchini R, Bertuccini L, et al. Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med Microbiol Immunol (Berl) 2001;190:113-120. (Pubitemid 33141332)
34. LaPlante KL, Mermel LA. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 2007;22:2239-2246. (Pubitemid 47248465)
35. Moskowitz SM, Foster JM, Emerson J, Burns JL. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004;42:1915-1922. (Pubitemid 38637802)
36. Knobloch JK, Von Osten H, Horstkotte MA, Rohde H, Mack D. Minimal attachment killing (MAK): A versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis. Med Microbiol Immunol (Berl) 2002;191: 107-114. (Pubitemid 35193366)
37. Patel R. Biofilms and antimicrobial resistance. Clin Orthop Relat Res 2005;437:41-47. (Pubitemid 41099064)
38. Jones RD, Jampani HB, Newman JL, Lee AS. Triclosan: A review of effectiveness and safety in health care settings. Am J Infect Control 2000;28: 184-196. (Pubitemid 30226494)
39. Food and Drug Administration. Over-the-counter drug products; safety and efficacy review; additional anti-gingivitis/antiplaque ingredient. Federal Register. 2004; 69:40640.
40. Volpe AR, Petrone ME, De Vizio W, Davies RM, Proskin HM. A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a fluoride dentifrice containing triclosan and PVM/MA copolymer. J Clin Dent 1996;7(Suppl.):S1-S14. (Pubitemid 26344828)
41. Triratana T, Rustogi KN, Volpe AR, DeVizio W, Petrone M, Giniger M. Clinical effect of a new liquid dentifrice containing triclosan/copolymer on existing plaque and gingivitis. J Am Dent Assoc 2002;133: 219-225.
42. Davies RM, Ellwood RP, Davies GM. The effectiveness of a toothpaste containing triclosan and polyvinyl-methyl ether maleic acid copolymer in improving plaque control and gingival health: A systematic review. J Clin Periodontol 2004;31:1029-1033. (Pubitemid 39643698)
43. Puig Silla M, Montiel Company JM, Almerich Silla JM. Use of chlorhexidine varnishes in preventing and treating periodontal disease. A review of the literature. Med Oral Patol Oral Cir Bucal 2008;13:E257-E260.
44. Cohen RE, Ciancio SG, Mather ML, Curro FA. Effect of vitamin E gel, placebo gel and chlorhexidine on periodontal disease. Clin Prev Dent 1991;13:20-24.
45. Russell AD. Chlorhexidine: Antibacterial action and bacterial resistance. Infection 1986;14:212-215. (Pubitemid 16002630)